cardiovascular benefits of glp-1 Receptor Agonists for the Reduction Atherosclerotic Risk in Patients With Type 2 Diabetes Cardiovascular Protection with a Long-Acting
Description
The list identifies these drugs for which the agency is working to reduce the impact of the shortage
J Immunotoxicol
PMCID: PMC12721889
Cardiology "1
Patients taking tirzepatide should be educated about symptoms that may indicate more serious complications or conditions requiring professional assessment
